scholarly journals Cardiovascular system and COVID-19

2021 ◽  
Vol 27 (3) ◽  
pp. 16-23
Author(s):  
Damyan Boychev ◽  
Naidenka Zlatareva ◽  
Ivo Petrov

The coronavirus disease 2019 (COVID-19) pandemic has affected health and economies around the globe at an unprecedented scale. Since the fi rst registered case of Covid-19 in December of 2019 until May 2021, more than 167 mil people have been infected and more than 3.5 mil have died. Patients with cardiovascular disease are one of the most affected groups. First, because cardiovascular disease, for example, stable angina or past myocardial infarction, weakens system’s abilities of dealing with stress due to infl ammation. Secondly, because COVID-19 is associated with multiple different mechanisms of cardiovascular injury. Developing COVID-19 related cardiovascular complications is associated with increased morbidity and mortality. The goal of this review is to present the known up to this moment mechanisms of cardiovascular injury and complications after COVID-19.

2019 ◽  
Vol 72 (5) ◽  
pp. 779-783
Author(s):  
Victor A. Ognev ◽  
Anna A. Podpriadova ◽  
Anna V. Lisova

Introduction:The high level of morbidity and mortality from cardiovascular disease is largely due toinsufficient influence on the main risk factors that contribute to the development of myocardial infarction.Therefore, a detailed study and assessment of risk factors is among the most important problems of medical and social importance. The aim: To study and evaluate the impact of biological, social and hygienic, social and economic, psychological, natural and climatic risk factors on the development of myocardial infarction. Materials and methods: A sociological survey was conducted in 500 people aged 34 to 85. They were divided into two groups. The main group consisted of 310 patients with myocardial infarction. The control group consisted of 190 practically healthy people, identical by age, gender and other parameters, without diseases of the cardiovascular system. Results: It was defined that 30 factors have a significant impact on the development of myocardial infarction.Data analysis revealed that the leading risk factors for myocardial infarction were biological and socio-hygienic. The main biological factors were: hypertension and hypercholesterolemia. The man socio-hygienic factor was smoking. Conclusions: Identification of risk factors provides new opportunities for the development of more effective approaches for the prevention and treatment of myocardial infarction.


2020 ◽  
Vol 18 (7.5) ◽  
pp. 1004-1006
Author(s):  
Javid J. Moslehi

Cardio-oncology is a growing field, due to several factors. These include the recognition that similar risk factors predispose people to both cardiovascular disease and cancer. In addition, certain cancers affect the heart, and cancer treatments can have short-term and long-lasting deleterious effects on the cardiovascular system. More than 40 years ago, it became evident that anthracyclines and radiation cause heart damage, and since then the list of cancer treatments that can harm the cardiovascular system has grown to include more modern treatments, such as anti-HER2 agents and angiogenesis inhibitors. Most recently, immune checkpoint inhibitors (ICIs) have been added to the list of cancer treatments that cause cardiovascular damage. ICI-associated myocarditis is a relatively rare but fatal complication that develops rapidly after initiating immunotherapy. Oncologists should be aware of the potential cardiovascular complications of cancer treatments, and should assess the cardiovascular health of all patients about to undergo therapy. Cancer survivors should be assessed and advised about prevention and treatment that may be needed to address cardiovascular disease.


2021 ◽  
Vol 8 ◽  
Author(s):  
Åslaug O. Matre ◽  
Anthea Van Parys ◽  
Thomas Olsen ◽  
Teresa R. Haugsgjerd ◽  
Carl M. Baravelli ◽  
...  

Background: Red and processed meat intake have been associated with increased risk of morbidity and mortality, and a restricted intake is encouraged in patients with cardiovascular disease. However, evidence on the association between total meat intake and clinical outcomes in this patient group is lacking.Objectives: To investigate the association between total meat intake and risk of all-cause mortality, acute myocardial infarction, cancer, and gastrointestinal cancer in patients with stable angina pectoris. We also investigated whether age modified these associations.Materials and Methods: This prospective cohort study consisted of 1,929 patients (80% male, mean age 62 years) with stable angina pectoris from the Western Norway B-Vitamin Intervention Trial. Dietary assessment was performed by the administration of a semi-quantitative food frequency questionnaire. Cox proportional hazards models were used to investigate the association between a relative increase in total meat intake and the outcomes of interest.Results: The association per 50 g/1,000 kcal higher intake of total meat with morbidity and mortality were generally inconclusive but indicated an increased risk of acute myocardial infarction [HR: 1.26 (95% CI: 0.98, 1.61)] and gastrointestinal cancer [1.23 (0.70, 2.16)]. However, we observed a clear effect modification by age, where total meat intake was associated with an increased risk of mortality and acute myocardial infarction among younger individuals, but an attenuation, and even reversal of the risk association with increasing age.Conclusion: Our findings support the current dietary guidelines emphasizing a restricted meat intake in cardiovascular disease patients but highlights the need for further research on the association between meat intake and health outcomes in elderly populations. Future studies should investigate different types of meat separately in other CVD-cohorts, in different age-groups, as well as in the general population.


Author(s):  
Lesley K Bowker ◽  
James D Price ◽  
Sarah C Smith

The ageing cardiovascular system 256 Chest pain 258 Stable angina 260 HOW TO . . . Rationalize antianginals in older patients 261 Acute coronary syndromes 262 Myocardial infarction 266 Hypertension 268 Hypertension: treatment 270 HOW TO . . . Use antihypertensives in a patient with comorbid conditions 271 Arrhythmia: presentation 272...


2021 ◽  
Vol 40 (2) ◽  
pp. 63-68
Author(s):  
Elizaveta V. Zbyshevskaya ◽  
Tatyana I. Makeeva ◽  
Fatima I. Bitakova ◽  
Marina N. Bakholdina ◽  
Elena V. Sivtsova ◽  
...  

In about 30% of cases, Sars-CoV-2 pneumonia is complicated by damage to the cardiovascular system myocardial infarction, pulmonary embolism, strokes, which are often fatal. There is still little data on the relationship between clinical manifestations and structural changes in the cardiovascular system during a new coronavirus infection. The material for the study was the data of the case histories and autopsies of 185 patients suffering from COVID-19 infection in the period SeptemberDecember 2020. In the deceased patients, a higher percentage of lung tissue damage was recorded on CT data, and a low level of oxygen saturation at the time of hospitalization. Most of the patients had a history of cardiovascular disease, diabetes mellitus, chronic kidney disease, and cancer. The pronounced course of systemic immune inflammation was manifested by a high average level of indicators such as D-dimmer, ferritin, C-reactive protein and fibrinogen. Among the causes of death, respiratory failure prevailed against the background of infectious-toxic shock. Damage to the cardiovascular system was manifested by the development of acute myocardial infarction, pulmonary embolism, stroke. Evaluation of the data of postmortem examination revealed a higher prevalence of stroke and a lower incidence of pulmonary embolism and acute myocardial infarction. In a histological study, damage to the cardiovascular system is represented by direct damage to the myocardium in the form of microcytolysis of cardiomyocytes with the development of necrotic areas. The data obtained from the analysis of the study results allow us to draw conclusions about the relationship between the severity of the course of a new coronavirus infection and the frequency of damage to the cardiovascular system, as well as make assumptions about individual links in the pathogenesis of cardiovascular disease in COVID-19 (1 figure, 2 tables, bibliography: 10 refs).


Proteomes ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 12
Author(s):  
Yaoli Xie ◽  
Zhijun Meng ◽  
Jia Gao ◽  
Caihong Liu ◽  
Jing Wang ◽  
...  

With continually improving treatment strategies and patient care, the overall mortality of cardiovascular disease (CVD) has been significantly reduced. However, this success is a double-edged sword, as many patients who survive cardiovascular complications will progress towards a chronic disorder over time. A family of adiponectin paralogs designated as C1q complement/tumor necrosis factor (TNF)-associated proteins (CTRPs) has been found to play a role in the development of CVD. CTRPs, which are comprised of 15 members, CTRP1 to CTRP15, are secreted from different organs/tissues and exhibit diverse functions, have attracted increasing attention because of their roles in maintaining inner homeostasis by regulating metabolism, inflammation, and immune surveillance. In particular, studies indicate that CTRPs participate in the progression of CVD, influencing its prognosis. This review aims to improve understanding of the role of CTRPs in the cardiovascular system by analyzing current knowledge. In particular, we examine the association of CTRPs with endothelial cell dysfunction, inflammation, and diabetes, which are the basis for development of CVD. Additionally, the recently emerged novel coronavirus (COVID-19), officially known as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has been found to trigger severe cardiovascular injury in some patients, and evidence indicates that the mortality of COVID-19 is much higher in patients with CVD than without CVD. Understanding the relationship of CTRPs and the SARS-CoV-2-related damage to the cardiovascular system, as well as the potential mechanisms, will achieve a profound insight into a therapeutic strategy to effectively control CVD and reduce the mortality rate.


2018 ◽  
Vol 25 (15) ◽  
pp. 1612-1620 ◽  
Author(s):  
Thomas Olsen ◽  
Kathrine J Vinknes ◽  
Gard FT Svingen ◽  
Eva R Pedersen ◽  
Indu Dhar ◽  
...  

Background Plasma total homocysteine (tHcy) has been implicated in the development of cardiovascular disease, but the mechanisms remain unclear. Vitamin A (Vit-A) is involved in homocysteine metabolism and we therefore explored the potential interaction between plasma tHcy and serum Vit-A in relation to incident acute myocardial infarction. Methods Cox proportional hazards models were used to assess the prospective relationships between tHcy and acute myocardial infarction in 2205 patients from Western Norway undergoing elective coronary angiography for suspected stable angina pectoris. Results are reported as hazard ratio per standard deviation increase in log-transformed tHcy. An interaction term for tHcy × Vit-A was added to multivariate models including age, sex, smoking, apolipoprotein B fasting, statin and aspirin prescription and estimated glomerular filtration rate. Results Geometric mean (geometric standard deviation) age of the participants (64.3% men) was 62.3 (1.24) years. Plasma tHcy was higher among participants in the upper versus lower Vit-A tertile. During 7 (2.4) years of follow-up, 15.1% suffered an AMI. A significant association of plasma tHcy with AMI in the total study population was observed. When we stratified the population according to Vit-A tertiles, plasma tHcy was associated with acute myocardial infarction only in the upper Vit-A tertile (hazard ratio per SD: 1.25, 95% confidence interval: 1.04–1.53, pinteraction = 0.03). Conclusions The risk relationship between plasma tHcy and acute myocardial infarction was modified by serum concentrations of Vit-A in patients with suspected stable angina pectoris. This finding may clarify the relationship between tHcy and cardiovascular disease.


Author(s):  
Gustavo Trindade Henriques Filho ◽  
Heloisa Ramos Lacerda ◽  
Afonso Albuquerque ◽  
Ricardo Arraes de Alencar Ximenes

As a result of the advances in the control of pulmonary insufficiency in tetanus, the cardiovascular system has increasingly been shown to be a determining factor in morbidity and mortality but detailed knowledge of the cardiovascular complications in tetanus is scanty. The 24h-Holter was carried out in order to detect arrhythmias and sympathetic overactivity in 38 tetanus patients admitted to an ICU. The SDNN Index (standard deviation from the normal R-to-R intervals), was useful in detecting adrenergic tonus, and ranged from 64.1 ± 27 in the more severe forms of tetanus to 125 ± 69 in the milder ones. Sympathetic overactivity occurred in 86.2% of the more severe forms of the disease, but was also detected in 33% of the milder forms. Half the patients had their sympathetic overactivity detected only by the Holter. The most frequent arrhythmias were isolated supraventricular (55.2%) and ventricular (39.4%) extrasystoles. There was no association of the arrhythmias with the clinical form of tetanus or with the presence of sympathetic overactivity. The present study demonstrated that major cardiovascular dysfunction, particularly sympathetic overactivity, occurs in all forms of tetanus, even in the milder ones. This has not been effectively detected with traditional monitoring in ICU and may not be properly treated.


2021 ◽  
Author(s):  
Jucier Gonçalves Júnior ◽  
Estelita Lima Cândido ◽  
Gislene Farias de Oliveira ◽  
Modesto Leite Rolim Neto

During SARS-CoV-1 and Middle East Respiratory Distress Syndrome (MERS) outbreaks it was observed a particularly elevated incidence of cardiovascular disease among patients. With COVID-19, this correlation becomes evident again. However, the cardiovascular impacts by COVID-19 pandemic are not yet well established although publications about its potential deleterious effects are constant. Thus, aimed to carry a systematic review of the literature with meta-analysis, the following question was used as a guide: what practical contributions does the scientific literature produced in the period of 2019-2020 has to offer about the impact of the COVID-19 on cardiovascular system? A systematic review of the literature using the Virtual Health Library (VHL) and PubMed with the following descriptors: #1 “cardiovascular disease” [MeSH] AND #2 “COVID-19” [keyword], as well as their equivalents in the Portuguese and Spanish language, during the period from December 2019 to March 2020 was performed. One hundred articles were found in Pubmed and twenty-seven were selected. In VHL there are 59 articles and four were selected totaling thirty-one papers. The findings were then divided into three subcategories: Etiology, Physiopathology and Risk factors of SARS-CoV-2 in Cardiovascular System; Clinical presentation, laboratory markers and imagenological aspects of SARS-CoV-2 in cardiovascular system; and Anti-Hypertensive Drugs, Cardiovascular System and SARS-CoV-2. When it comes to the cardiovascular system, these issues are aggravated and urge as a joint commitment from researchers, medical and governmental organizations to carry out more robust studies with bold methodologies aimed at mapping prognostic factors and assertive therapeutic approaches in the management of cardiovascular complications of COVID- 19.


2020 ◽  
Author(s):  
Chan Chen ◽  
Yang Lou ◽  
Xin-Yi Li ◽  
Zheng-Tian Lv ◽  
Lu-Qiu Zhang ◽  
...  

Abstract Background: Mesenchymal stem cells (MSCs) have important research value and broad application prospects in the cardiovascular disease. This study in order to provide information on the latest progress, evolutionary path, frontier research hotspots and future research developmental trends in this field. Methods: A knowledge map was generated by CiteSpace and VOSviewer analysis software based on data obtained from the literature on MSCs in the cardiovascular field.Results: The USA and China ranked at the top in terms of the percentage of articles, accounting for 34.306% and 28.550%, respectively. The institution with the highest number of research publications in this field was the University of Miami, followed by the Chinese Academy of Medical Sciences and Harvard University. The research institution with the highest ACI value was Harvard University, followed by the Mayo Clinic and the University of Cincinnati.The top three subjects in terms of the number of published articles were cell biology, cardiovascular system cardiology and research experimental medicine. The journal with the most publications in this field was Circulation Research, followed by Scientific Reports and Biomaterials. The direction of research on MSCs in the cardiovascular system was divided into four parts: (1) tissue engineering and gene and material research, (2) cell transplantation and signal transduction pathway research, (3) assessment of the efficacy of the use of stem cells from different sources in the treatment of acute myocardial infarction, and (4) myocardial hypertrophy, heart failure and myocardial infarction regeneration and repair research. Tissue research is the hotspot and frontier in this field.Conclusion: MSC research has presented a gradual upward trend in the cardiovascular field. Multidisciplinary intersection is a characteristic of this field. Engineering and materials disciplines are particularly valued and have received attention from researchers. The progress in multidisciplinary research will provide motivation and technical support for the development of this field.


Sign in / Sign up

Export Citation Format

Share Document